JointFlex
JointFlex, licence 80085163: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Strides Global Consumer Healthcare Ltd
- NPN or DIN-HM
- 80085163
- Status
- Active licence
- Licence date
- 14 May 2018
- Revision date
- 5 February 2021
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de chondroïtine Source : Requin - Cartilage | 7.2 mg/g | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine sulfate | 3.0 mg/g | Not calculated |
| dl-Camphre Source : dl-Camphre | 32.0 mg/g | Not calculated |
| Cartilage de requin Source : Cartilage de requin | 14.0 mg/g | Not calculated |
Non-medicinal ingredients
Acétate de d-alpha tocophéryle, Eau purifiée, Sesquistéarate de méthyl glucose, Hydroxyde de potassium, Stéarate de diméthiconol, Benzoate d'alkyle en C12 à 15, Poly(sorbate) 20, Methyl gluceth-20, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Glycérine, Butylcarbamate d'iodopropynyle, Carbomère de potassium, Huile de safran des Indes, Jus de feuilles d'Aloe Barbadensis, Hydroxypropyl méthylcellulose, Lanoline hydroxylée, Diazolidinyl urée, EDTA de sodium, Alcool de lanoline acétylée, Monostéarate de glycéryle, DL-Panthénol, Diméthicone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4.0 g | minimum: 1.0 Jour(s) ; maximum: 4.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis. Effective in reducing joint pain. Helps to relieve osteoarthritic pain. Helps to relieve symptoms of bone and joint pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085163
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.